Notably, S713 phosphorylation in KRAS-mutant A549 lung cancer cells seems to be critical for the stability of CHD3 protein, as S713A mutation dramatically inhibited CHD3 protein expression, whereas the phosphorylation mimicking mutation S173D resulted in increased protein expression (Fig 3F). Here, KRAS is linked to lung carcinoma.